Captrust Financial Advisors Baxter International Inc Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Baxter International Inc stock. As of the latest transaction made, Captrust Financial Advisors holds 49,924 shares of BAX stock, worth $1.66 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

49,924

Previous 58,352 14.44%

Holding current value

$1.66 Million

Previous $1.95 Million 2.87%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$32.85 - $40.26 $276,859 - $339,311	-8,428 Reduced 14.44%	49,924 $1.9 Million
Q2 2024 Aug 14, 2024	SELL	$32.87 - $43.55 $589,589 - $781,156	-17,937 Reduced 23.51%	58,352 $1.95 Million
Q1 2024 May 15, 2024	SELL	$37.88 - $43.77 $200,915 - $232,156	-5,304 Reduced 6.5%	76,289 $3.26 Million
Q4 2023 Feb 14, 2024	SELL	$31.71 - $38.95 $249,113 - $305,991	-7,856 Reduced 8.78%	81,593 $3.15 Million
Q3 2023 Nov 14, 2023	BUY	$37.32 - $49.29 $298 - $394	8 Added 0.01%	89,449 $3.38 Million
Q2 2023 Aug 14, 2023	BUY	$39.98 - $47.68 $21,829 - $26,033	546 Added 0.61%	89,441 $4.07 Million
Q1 2023 May 15, 2023	BUY	$37.58 - $52.57 $42,953 - $60,087	1,143 Added 1.3%	88,895 $3.61 Million
Q4 2022 Feb 15, 2023	BUY	$49.7 - $57.71 $268,032 - $311,230	5,393 Added 6.55%	87,752 $4.47 Million
Q3 2022 Nov 16, 2022	BUY	$53.86 - $66.8 $217,863 - $270,206	4,045 Added 5.17%	82,359 $4.44 Million
Q2 2022 Aug 23, 2022	SELL	$63.83 - $80.0 $122,170 - $153,120	-1,914 Reduced 2.39%	78,314 $5.05 Million
Q2 2022 Aug 16, 2022	BUY	$63.83 - $80.0 $696,385 - $872,800	10,910 Added 15.74%	80,228 $5.15 Million
Q1 2022 May 16, 2022	BUY	$76.85 - $89.45 $243,691 - $283,645	3,171 Added 4.79%	69,318 $5.39 Million
Q4 2021 Feb 14, 2022	BUY	$74.57 - $87.19 $124,830 - $145,956	1,674 Added 2.6%	66,147 $5.7 Million
Q3 2021 Nov 16, 2021	SELL	$73.77 - $83.61 $90,220 - $102,255	-1,223 Reduced 1.86%	64,473 $5.2 Million
Q2 2021 Aug 16, 2021	SELL	$80.5 - $88.01 $239,246 - $261,565	-2,972 Reduced 4.33%	65,696 $5.31 Million
Q1 2021 May 17, 2021	BUY	$76.38 - $86.03 $418,715 - $471,616	5,482 Added 8.68%	68,668 $5.81 Million
Q4 2020 Feb 16, 2021	SELL	$75.39 - $82.36 $586,835 - $641,090	-7,784 Reduced 10.97%	63,186 $5.09 Million
Q3 2020 Nov 17, 2020	BUY	$78.33 - $90.73 $35,796 - $41,463	457 Added 0.65%	70,970 $5.66 Million
Q2 2020 Aug 14, 2020	BUY	$78.66 - $94.14 $86,683 - $103,742	1,102 Added 1.59%	70,513 $6.16 Million
Q1 2020 May 15, 2020	SELL	$71.57 - $93.3 $82,734 - $107,854	-1,156 Reduced 1.64%	69,411 $5.46 Million
Q4 2019 Feb 14, 2020	BUY	$76.7 - $88.45 $2.51 Million - $2.89 Million	32,716 Added 86.43%	70,567 $6.06 Million
Q3 2019 Nov 14, 2019	SELL	$81.4 - $89.78 $93,365 - $102,977	-1,147 Reduced 2.94%	37,851 $3.32 Million
Q2 2019 Aug 13, 2019	BUY	$73.44 - $82.41 $114,492 - $128,477	1,559 Added 4.16%	38,998 $3.2 Million
Q1 2019 May 15, 2019	SELL	$64.48 - $81.31 $51,906 - $65,454	-805 Reduced 2.1%	37,439 $3.05 Million
Q4 2018 Feb 13, 2019	SELL	$61.45 - $77.8 $15,178 - $19,216	-247 Reduced 0.64%	38,244 $2.52 Million
Q3 2018 Nov 15, 2018	BUY	$70.71 - $77.75 $2.39 Million - $2.62 Million	33,762 Added 713.94%	38,491 $2.98 Million
Q2 2018 Aug 13, 2018	BUY	$63.43 - $75.41 $23,088 - $27,449	364 Added 8.34%	4,729 $350,000
Q1 2018 May 15, 2018	BUY	$62.56 - $72.26 $1,939 - $2,240	31 Added 0.72%	4,365 $277,000
Q4 2017 Feb 14, 2018	BUY	$61.45 - $66.05 $127,078 - $136,591	2,068 Added 91.26%	4,334 $281,000
Q3 2017 Feb 16, 2018	BUY	$59.5 - $64.61 $134,827 - $146,406	2,266	2,266 $146,000

Others Institutions Holding BAX

# of Institutions

1,006

Shares Held

451M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Baxter International Inc Transaction History